As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...

Practical guidance for sponsors to extract meaningful insight—and avoid costly surprises— when vetting CDMO partners.

Forward-thinking CDMOs are redefining collaboration by helping brand owners translate consumer insight into differentiated, ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

From legacy therapeutics to next-generation GLP-1s, advances in synthesis, analysis, and regulation are reshaping how peptide ...

Reframing pharmaceutical production around process stability, real-time quality assurance, and regulatory alignment in the ...

At DCAT Week 2026, Contract Pharma spoke with Aniel Khubchandani, Aragen Life Sciences CEO, Development & Manufacturing ...